SC 13D

Company

BridgeBio Pharma, Inc.

Filed

July 10, 2019

Accession Number

0001140361-19-012746

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →